C4 Therapeutics, Inc.
CCCC· Nasdaq
Feb 25, before the open
Thu, Feb 25, 2027in 98 days
Projected from its last 8 releases. The company has not named the day yet.
Up after 7 of 9, down after 2.
C4 Therapeutics, Inc. · CIK 1662579 · Engraved from SEC EDGAR
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Based on 6 prior 10-K filings.
The stock’s move from the last close before each release to the first close after it, over the last 9 releases. Largest: +31.1% after Q2 2025.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.